IncFact
Company Profiles: Revenue, Growth, Competition

4E Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for 4E Therapeutics

Access the complete profile.

4E Therapeutics Fast Facts

RevenueN/A    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry N/A
Address3800 N Lamar Blvd Ste 200
Austin, TX 78756

Note: Revenues for privately held companies are statistical evaluations.


4E Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • 4E Therapeutics is classified as operating in the N/A industry, NAICS Code .


Investor Activity

4E Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
November 12, 2021 23 95%$2 MM
Complete list of funding rounds and total amounts in the Company Report




Nearby Competitors

These companies are similar in business line and location to 4E Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
WHOLE FOODS MARKETAustin, TX100 
OTTO BOCK HEALTHCAREAustin, TX21 
COMBINED LAW ENFORCEMENT ASSOC. OF TEXASAustin, TX20 
SMW HEALTH NETWORKAustin, TX20 
SUMMA MUNUSAustin, TX20 
TEXAS ENTERPRISESAustin, TX11 




Other Companies at 3800 N Lamar Blvd Ste 200, Austin TX

Company HeadquartersRevenue ($ MM)
EXSTRATUSAustin, TX100 
STANFORD CAMPAIGNSAustin, TX20 
DAVIS GROUPAustin, TX17 
OPERATOR FOUNDATIONAustin, TX0 
SIMPAT TECHAustin, TX0 


(0.1387 s)



Future Competition: 4E Therapeutics's Fastest Growing Competitors

These companies are in the same general field as 4E Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
4E Therapeutics Competitors